To add to the veritable cartload of recent papers issued as a part of the ongoing review of MiFID (see some of the reference data aspects summarised here and more coverage here), the Committee of European Securities Regulators (CESR) has added two more into the mix, this time on the subject of OTC derivatives, thus increasing the number of potential data requirements for firms on the regulatory reform list. The consultation paper on transaction reporting for OTC derivatives proposes to increase the scope of firms’ obligations to report these instruments, including key reference data items, whereas the paper on the standardisation and trading of derivatives adds in new standardised data requirements.

Want to know what we have to say about this? Get free access to this and more stories by signing up for a free trial (or free access if you work at a financial institution) with no obligation below, or login if you’re already a member

Existing Users Login

Sign up for Complimentary Access or Subscribe to Read this Article

For instant access to our A-Team Insight content, you can sign up for 30-day complimentary access to the full content of our news services. This will enable you to read the latest in-depth analysis on the stories that matter to you, access and search our full archives, and receive the latest monthly issue of A-Team Insight in convenient PDF format.

You may qualify for annual complimentary access if you are a senior manager at a financial institution (bank, brokerage, asset management firm, etc.).

For more information or to register, CLICK HERE for instant complimentary access.

Already like what you've seen and know you want to subscribe? An annual subscription is priced at £495/$795 and gives full access for up to three people to all our online content and the monthly A-Team Insight digest of the top news in PDF format. CLICK HERE to subscribe now.